The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analy
published in: Diabetes, Obesity and Metabolism
date of publication: 2018-03-25
main subject: hypoglycemia
Cites articles 35
- 2010-02-01
Date
Title
Article - wd:Q49928678